186 related articles for article (PubMed ID: 30175467)
1. New method to preserve the original proportion and integrity of urinary cell-free DNA.
Li P; Ning J; Luo X; Du H; Zhang Q; Zhou G; Du Q; Ou Z; Wang L; Wang Y
J Clin Lab Anal; 2019 Feb; 33(2):e22668. PubMed ID: 30175467
[TBL] [Abstract][Full Text] [Related]
2. Diagnostic value of combined IQGAP3/BMP4 and IQGAP3/FAM107A expression ratios in urinary cell-free DNA for discriminating bladder cancer from hematuria.
Xu Y; Kim YH; Jeong P; Piao XM; Byun YJ; Kang HW; Kim WT; Lee JY; Kim IY; Moon SK; Choi YH; Yun SJ; Kim WJ
Urol Oncol; 2019 Jan; 37(1):86-96. PubMed ID: 30446454
[TBL] [Abstract][Full Text] [Related]
3. Urinary Cell-Free DNA Quantification as Non-Invasive Biomarker in Patients with Bladder Cancer.
Brisuda A; Pazourkova E; Soukup V; Horinek A; Hrbáček J; Capoun O; Svobodova I; Pospisilova S; Korabecna M; Mares J; Hanuš T; Babjuk M
Urol Int; 2016; 96(1):25-31. PubMed ID: 26338254
[TBL] [Abstract][Full Text] [Related]
4. Fragmentation patterns of cell-free DNA and somatic mutations in the urine of metastatic breast cancer patients.
Lin S; Wang S; Xu B
J Cancer Res Ther; 2024 Apr; 20(2):563-569. PubMed ID: 38454812
[TBL] [Abstract][Full Text] [Related]
5. Fragmentomics of urinary cell-free DNA in nuclease knockout mouse models.
Chen M; Chan RWY; Cheung PPH; Ni M; Wong DKL; Zhou Z; Ma ML; Huang L; Xu X; Lee WS; Wang G; Lui KO; Lam WKJ; Teoh JYC; Ng CF; Jiang P; Chan KCA; Chiu RWK; Lo YMD
PLoS Genet; 2022 Jul; 18(7):e1010262. PubMed ID: 35793278
[TBL] [Abstract][Full Text] [Related]
6. Urine cell-free DNA as a promising biomarker for early detection of non-small cell lung cancer.
Ren S; Ren XD; Guo LF; Qu XM; Shang MY; Dai XT; Huang Q
J Clin Lab Anal; 2020 Aug; 34(8):e23321. PubMed ID: 32281142
[TBL] [Abstract][Full Text] [Related]
7. Urinary Cell-Free DNA IQGAP3/BMP4 Ratio as a Prognostic Marker for Non-Muscle-Invasive Bladder Cancer.
Xu Y; Kim YH; Jeong P; Piao XM; Byun YJ; Seo SP; Kang HW; Kim WT; Lee JY; Ryu DH; Choi JW; Kim IY; Moon SK; Choi YH; Yun SJ; Kim WJ
Clin Genitourin Cancer; 2019 Jun; 17(3):e704-e711. PubMed ID: 31088707
[TBL] [Abstract][Full Text] [Related]
8. Urinary Biomarkers in Tumors: An Overview.
Cimmino I; Bravaccini S; Cerchione C
Methods Mol Biol; 2021; 2292():3-15. PubMed ID: 33651347
[TBL] [Abstract][Full Text] [Related]
9. Emerging Utility of Urinary Cell-free Nucleic Acid Biomarkers for Prostate, Bladder, and Renal Cancers.
Lin SY; Linehan JA; Wilson TG; Hoon DSB
Eur Urol Focus; 2017 Apr; 3(2-3):265-272. PubMed ID: 28753876
[TBL] [Abstract][Full Text] [Related]
10. Concentration and integrity indexes of urine cell-free DNA as promising biomarkers for early lung cancer diagnosis.
Ren S; Ren X; Guo H; Liang L; Wei K; Guo L; Qu X; Dai X; Huang Q
Per Med; 2021 Mar; 18(2):129-139. PubMed ID: 33565322
[No Abstract] [Full Text] [Related]
11. Urinary Cell-Free DNA: Potential and Applications.
Salvi S; Casadio V
Methods Mol Biol; 2019; 1909():201-209. PubMed ID: 30580433
[TBL] [Abstract][Full Text] [Related]
12. Urinary Cell-Free DNA in Bladder Cancer Detection.
Tse RT; Zhao H; Wong CY; Cheng CK; Kong AW; Peng Q; Chiu PK; Ng CF; Teoh JY
Diagnostics (Basel); 2021 Feb; 11(2):. PubMed ID: 33672869
[TBL] [Abstract][Full Text] [Related]
13. Urinary Cell-Free DNA Integrity Analysis.
Casadio V; Salvi S
Methods Mol Biol; 2021; 2292():17-22. PubMed ID: 33651348
[TBL] [Abstract][Full Text] [Related]
14. Diagnostic Potential of Circulating Tumor Cells, Urinary MicroRNA, and Urinary Cell-Free DNA for Bladder Cancer: A Review.
Koguchi D; Matsumoto K; Shiba I; Harano T; Okuda S; Mori K; Hirano S; Kitajima K; Ikeda M; Iwamura M
Int J Mol Sci; 2022 Aug; 23(16):. PubMed ID: 36012417
[TBL] [Abstract][Full Text] [Related]
15. Impact of Cell-Debris and Room-Temperature Storage on Urine Circulating Tumor DNA from Hepatocellular Carcinoma.
Kim AK; Lin SY; Wang Z; Luu H; Hamilton JP; Song W; Su YH
J Mol Diagn; 2023 Dec; 25(12):913-920. PubMed ID: 37813297
[TBL] [Abstract][Full Text] [Related]
16. A protocol for urine collection and storage prior to DNA methylation analysis.
Bosschieter J; Bach S; Bijnsdorp IV; Segerink LI; Rurup WF; van Splunter AP; Bahce I; Novianti PW; Kazemier G; van Moorselaar RJA; Steenbergen RDM; Nieuwenhuijzen JA
PLoS One; 2018; 13(8):e0200906. PubMed ID: 30142219
[TBL] [Abstract][Full Text] [Related]
17. Quantitative RNA Analysis from Urine Using Real Time PCR.
Mengual L; Olivan M
Methods Mol Biol; 2018; 1655():227-237. PubMed ID: 28889389
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of TERT promoter mutations in urinary cell-free DNA and sediment DNA for detection of bladder cancer.
Stasik S; Salomo K; Heberling U; Froehner M; Sommer U; Baretton GB; Ehninger G; Wirth MP; Thiede C; Fuessel S
Clin Biochem; 2019 Feb; 64():60-63. PubMed ID: 30528938
[TBL] [Abstract][Full Text] [Related]
19. The potential use of urine cell free DNA as a marker for cancer.
Salvi S; Martignano F; Molinari C; Gurioli G; Calistri D; De Giorgi U; Conteduca V; Casadio V
Expert Rev Mol Diagn; 2016 Dec; 16(12):1283-1290. PubMed ID: 27796148
[TBL] [Abstract][Full Text] [Related]
20. UBE2C cell-free RNA in urine can discriminate between bladder cancer and hematuria.
Kim WT; Jeong P; Yan C; Kim YH; Lee IS; Kang HW; Kim YJ; Lee SC; Kim SJ; Kim YT; Moon SK; Choi YH; Kim IY; Yun SJ; Kim WJ
Oncotarget; 2016 Sep; 7(36):58193-58202. PubMed ID: 27528424
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
